Antigenics to Webcast 2010 Annual Shareholders Meeting

LEXINGTON, Mass.--(BUSINESS WIRE)-- Antigenics Inc. (NASDAQ: AGEN) invites investors and the general public to its 2010 Annual Shareholders Meeting at 5:00 p.m. ET on Wednesday, May 12. The meeting will be held at the company's headquarters at 3 Forbes Road, Lexington, MA 02421. Registration for attendees starts at 4:30 p.m. ET.

A live webcast will be accessible from the company’s website at www.antigenics.com/webcast/ and will be archived and available for replay approximately two hours after the meeting.

Antigenics is a biotechnology company developing treatments for cancers and infectious diseases. For more information, please visit www.antigenics.com.



CONTACT:

Antigenics
Media: Brad Miles, 212-477-9007 x 17
or
Investors:
Shalini Sharp, 800-962-2436

KEYWORDS:   United States  North America  Massachusetts

INDUSTRY KEYWORDS:   Health  Biotechnology  Infectious Diseases  Oncology  Pharmaceutical

MEDIA:

Logo
 Logo

Suggested Articles

Barely two years after paying up $263 million for the ex-Asia rights to BeiGene’s tislelizumab, Celgene is bowing out—to the tune of $150 million.

A University of Pennsylvania team discovered that a protein called TOX helps determine the fate of exhausted T cells in cancer and other diseases.

AstraZeneca is set to spend $630 million on R&D in South Korea over the next five years as part of a wider cooperative agreement.